456 related articles for article (PubMed ID: 35576833)
1. Immunoinformatic approach for the construction of multi-epitopes vaccine against omicron COVID-19 variant.
Khan K; Khan SA; Jalal K; Ul-Haq Z; Uddin R
Virology; 2022 Jul; 572():28-43. PubMed ID: 35576833
[TBL] [Abstract][Full Text] [Related]
2. Immunoinformatic-guided designing of multi-epitope vaccine construct against Brucella Suis 1300.
Jalal K; Khan K; Uddin R
Immunol Res; 2023 Apr; 71(2):247-266. PubMed ID: 36459272
[TBL] [Abstract][Full Text] [Related]
3. A conserved subunit vaccine designed against SARS-CoV-2 variants showed evidence in neutralizing the virus.
Kibria KMK; Faruque MO; Islam MSB; Ullah H; Mahmud S; Miah M; Saleh AA
Appl Microbiol Biotechnol; 2022 Jun; 106(11):4091-4114. PubMed ID: 35612630
[TBL] [Abstract][Full Text] [Related]
4. In silico SARS-CoV-2 vaccine development for Omicron strain using reverse vaccinology.
Li V; Lee C; Yoo D; Cho S; Kim H
Genes Genomics; 2022 Aug; 44(8):937-944. PubMed ID: 35665465
[TBL] [Abstract][Full Text] [Related]
5. Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2.
Tahir Ul Qamar M; Shahid F; Aslam S; Ashfaq UA; Aslam S; Fatima I; Fareed MM; Zohaib A; Chen LL
Infect Dis Poverty; 2020 Sep; 9(1):132. PubMed ID: 32938504
[TBL] [Abstract][Full Text] [Related]
6. Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches.
Safavi A; Kefayat A; Mahdevar E; Abiri A; Ghahremani F
Vaccine; 2020 Nov; 38(48):7612-7628. PubMed ID: 33082015
[TBL] [Abstract][Full Text] [Related]
7. Reverse vaccinology approach for multi-epitope centered vaccine design against delta variant of the SARS-CoV-2.
Jalal K; Khan K; Basharat Z; Abbas MN; Uddin R; Ali F; Khan SA; Hassan SSU
Environ Sci Pollut Res Int; 2022 Aug; 29(40):60035-60053. PubMed ID: 35414157
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics approach for the construction of multiple epitope vaccine against omicron variant of SARS-CoV-2.
Zaib S; Akram F; Liaqat ST; Altaf MZ; Khan I; Dera AA; Uddin J; Khan A; Al-Harrasi A
Sci Rep; 2022 Nov; 12(1):19087. PubMed ID: 36352060
[TBL] [Abstract][Full Text] [Related]
9. Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approaches.
Tahir Ul Qamar M; Rehman A; Tusleem K; Ashfaq UA; Qasim M; Zhu X; Fatima I; Shahid F; Chen LL
PLoS One; 2020; 15(12):e0244176. PubMed ID: 33351863
[TBL] [Abstract][Full Text] [Related]
10. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.
Yang Z; Bogdan P; Nazarian S
Sci Rep; 2021 Feb; 11(1):3238. PubMed ID: 33547334
[TBL] [Abstract][Full Text] [Related]
11. A reverse vaccinology and immunoinformatics approach for designing a multiepitope vaccine against SARS-CoV-2.
Jahangirian E; Jamal GA; Nouroozi M; Mohammadpour A
Immunogenetics; 2021 Dec; 73(6):459-477. PubMed ID: 34542663
[TBL] [Abstract][Full Text] [Related]
12. Vaccinomic approach for novel multi epitopes vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
Almofti YA; Abd-Elrahman KA; Eltilib EEM
BMC Immunol; 2021 Mar; 22(1):22. PubMed ID: 33765919
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatics-based SARS-CoV-2 epitopes design and the impact of spike protein mutants on epitope humoral immunities.
Sun Q; Huang Z; Yang S; Li Y; Ma Y; Yang F; Zhang Y; Xu F
Immunobiology; 2022 Nov; 227(6):152287. PubMed ID: 36244092
[TBL] [Abstract][Full Text] [Related]
14. Reverse vaccinology-based prediction of a multi-epitope SARS-CoV-2 vaccine and its tailoring to new coronavirus variants.
Ezzemani W; Kettani A; Sappati S; Kondaka K; El Ossmani H; Tsukiyama-Kohara K; Altawalah H; Saile R; Kohara M; Benjelloun S; Ezzikouri S
J Biomol Struct Dyn; 2023 Jul; 41(11):4917-4938. PubMed ID: 35549819
[TBL] [Abstract][Full Text] [Related]
15. Whole proteome screening and identification of potential epitopes of SARS-CoV-2 for vaccine design-an immunoinformatic, molecular docking and molecular dynamics simulation accelerated robust strategy.
Ezaj MMA; Junaid M; Akter Y; Nahrin A; Siddika A; Afrose SS; Nayeem SMA; Haque MS; Moni MA; Hosen SMZ
J Biomol Struct Dyn; 2022 Sep; 40(14):6477-6502. PubMed ID: 33586620
[TBL] [Abstract][Full Text] [Related]
16. A novel vaccine based on SARS-CoV-2 CD4
Palatnik-de-Sousa I; Wallace ZS; Cavalcante SC; Ribeiro MPF; Silva JABM; Cavalcante RC; Scheuermann RH; Palatnik-de-Sousa CB
Sci Rep; 2022 Oct; 12(1):16731. PubMed ID: 36202985
[TBL] [Abstract][Full Text] [Related]
17. A vaccine built from potential immunogenic pieces derived from the SARS-CoV-2 spike glycoprotein: A computational approximation.
Marchan J
J Immunol Methods; 2022 Mar; 502():113216. PubMed ID: 35007561
[TBL] [Abstract][Full Text] [Related]
18. Identification of vaccine targets & design of vaccine against SARS-CoV-2 coronavirus using computational and deep learning-based approaches.
Abbasi BA; Saraf D; Sharma T; Sinha R; Singh S; Sood S; Gupta P; Gupta A; Mishra K; Kumari P; Rawal K
PeerJ; 2022; 10():e13380. PubMed ID: 35611169
[TBL] [Abstract][Full Text] [Related]
19. A Next-Generation Vaccine Candidate Using Alternative Epitopes to Protect against Wuhan and All Significant Mutant Variants of SARS-CoV-2: An Immunoinformatics Approach.
Bhattacharya M; Sharma AR; Ghosh P; Lee SS; Chakraborty C
Aging Dis; 2021 Dec; 12(8):2173-2195. PubMed ID: 34881093
[TBL] [Abstract][Full Text] [Related]
20. Multiple epitope-based vaccine prediction against SARS-CoV-2 spike glycoprotein.
Sirohi PR; Gupta J; Somvanshi P; Prajapati VK; Grover A
J Biomol Struct Dyn; 2022 May; 40(8):3347-3358. PubMed ID: 33246394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]